About this trial

The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors

Eligibility criteria

Qualifiers

chromosomal deletion proven by FISH examination

Disqualifiers

None

Trial design

Treatments tested in this trial

  • methylphenidate, fluoxetin, risperidone

Treatment groups

400 Participants
are divided into 1 treatment group

Locations

1
Schneider Children's Mediac Center of Israel49202, Petah Tikva Israel

Sponsors and collaborators

The Chaim Sheba Medical Center

Lead sponsor